Published in Blood Weekly, January 25th, 2007
Study 1: A report, "Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits," is newly published data in Clinical and Experimental Pharmacology and Physiology. According to recent research from Gifu, Japan, "1. In the present study, we investigated the effect of 3-methyl-1-phenyl-2-pyrazolin-5-one (edaravone), a free radical scavenger, on myocardial infarct (MI) size and cardiac function in an in vivo model of MI in rabbits."
"We further investigated the contribution of hydroxyl radicals, superoxide and nitric...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.